Microdosing magic? small psilocybin doses tested for depression
NCT ID NCT05259943
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study tested whether very small, non-hallucinogenic doses of psilocybin (2 mg) could safely improve mood in 39 adults with major depressive disorder. Participants took the microdose and researchers measured changes in depression, anxiety, and physical symptoms using a standard questionnaire. The goal was to see if this approach could ease symptoms without causing a full psychedelic experience.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Psych Research
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.